Index

Acute catastrophic demise (Continued) Adenofibroma, 870–874, 870f–875f

A umbilical cord prolapse and, 1183–1184 cervical, 447
ABCs. See Adenoid basal carcinomas uterine rupture and, 1188–1189 endometrioid, 895
Abdomen, ectopic pregnancy in, 1089 Acute inflammatory cells, 1161 of fallopian tube, 744, 748f
Ablation, 519 Acute villitis, 1167, 1169f Müllerian, 286
endometrial, for abnormal uterine Acyclovir, 94 Adenoid basal carcinomas (ABCs), 406f
bleeding, 490 AD. See Atopic dermatitis of cervix, 406–408
submucosal leiomyomata/fibroid and, Adenocarcinoma. See also Glandular Adenoid cystic carcinomas (ACCs), 407f
519 neoplasia; specific diseases or disease of Bartholin gland, 172–174, 173f–174f
Abnormal uterine bleeding, 471, 486–490 sites of cervix, 406–408
in fourth decade, causes of, 490t in anal canal, 227 Adenolipoma, 209
in fifth decades, 471 of anal mucosa, 249–250 Adenoma, of Bartholin gland, 111, 112f
causes of, 490t of anus, 249–250 Adenoma malignum, 408, 409f
in sixth decade, 490t of Bartholin gland, 174 endometrioid, 413f
causes of, 472f cervical neuroendocrine carcinoma and, glandular hyperplasia and, 408–412,
clinical evaluation for, 486–488 431 408t
definitions of, 472t of cervix Adenomatoid tumors, 699, 699f
diagnostic considerations according to age categories of, 400b of fallopian tube, 741–742, 744f–745f
for, 488–489 diagnosis and management of, of peritoneum, 831
diagnostic evaluation of, 488 401–422 Adenomatous polyposis coli (APC), 822
endometrial adenocarcinoma and, 589 HPV and, 375–376 Adenomyoma, 445–447
endometrial polyp and, 490t, 493 endometrioid intraepithelial neoplasia atypical polypoid, 698, 698f–699f
hysteroscopy for, 487–488 and, 534 clinical background of, 445
management of, 489–490 endometriosis and, 286f diagnostic criteria for, 445–447
oral contraceptive therapy and, 488–489 of fistula, 250 differential diagnosis of, 446–447
from placenta previa, 1236 HP and, 107–109 gross exam for, 445
from placental abruption, 1228 HRT and, 806–807 histologic features of, 445–446, 446f
submucosal leiomyoma/fibroid and, 504 infiltrative invasion of, 398f immunohistochemistry of, 446
in third and fourth decades, 471 intestinal endometriosis and, 807f outcome and management for, 447
Abortion. See Postabortion complications; invasive endocervical, 399–401 uterine smooth muscle tumors and,
Recurrent pregnancy loss; Spontaneous metastatic, 438f 697–699, 698f
abortion to cervix, 415–416, 416t Adenomyomatous polyp, endometrial polyp
Abruptio placentae. See Placental abruption oral contraceptives and, 375–376 and, 493, 495f
Abruption-oligohydramnios sequence, ovarian endometriosis and, 806–807 Adenomyosis, 487
chronic, 1223–1224 reactive endocervical cells and, 379–380, endometrial adenocarcinoma and,
Abscess 380f–381f 623–631, 624f
of anus, 231 smoking and, 376 uterine smooth muscle tumors and,
fungal funisitis with superficial of vagina, 285–286 697–699, 697f–698f
microabscesses, 1157f of vulva, 165–172 Adenosarcoma, 699–702, 700f–701f, 924
ovarian, 790f Adenocarcinoma in situ (AIS), 375, carcinosarcomas and, 637f
periclitoral, 85–86, 85f 377f–378f, 380f cervical, 447–449
Absent vagina, 16 adenosquamous carcinoma and, 388 clinical background of, 447
Acantholytic dermatosis of vulvocrural area cervical intraepithelial neoplasia and, 385 differential diagnosis of, 449,
(ADV), 43–44, 44f. See also Grover columnar differentiation and, 403, 403f 450f–451f
disease criteria for, 377 gross exam for, 447
differential diagnosis of, 41t diagnosis and management of, 385–401 histologic features of, 447–448, 448f
Acantholytic dyskeratosis, 119 differential diagnosis of, 388–390 immunohistochemistry of, 448
Acardiac twinning, 1240–1241, 1242f with early invasion, 398f outcome and management for, 449
Accelerated delivery, 1219–1225 endocervical subtype of, 385–387 clinical presentation of, 699–700
ACCs. See Adenoid cystic carcinomas endometrioid carcinoma and, 402 definition of, 699
Achilles’ tendon, Reiter syndrome and, 30 endometrioid subtype of, 387 differential diagnosis of, 701–702, 702f
Acid-fast bacilli (AFB), 498 false-negative interpretations with, endometrial polyp and, 496f
Acne vulgaris, 70 379–380 histopathologic features of, 700
Acquired immunodeficiency syndrome histologic criteria for, 388t molecular features of, 702
(AIDS) HPV and, 375–376 prognosis and management of, 702
anus and, 233 HSIL and, 383, 384f rhabdomyosarcoma and, 701f
fetal death caused by, 1199 intestinal subtype of, 387, 387f Adenosquamous carcinoma, 403f
SD and, 31 menstrual or directly sampled of cervix, 402–403
Acquired lymphangiectasia, 214–215, 215f endometrial cells and, 379, 380f clear cell, 403–404
Actinomyces israelii, 503–504 Pap smears for, 375 glassy cell, 403–404, 404f
Actinomycosis, 503–504 reactive endocervical cells and, 379–380, of vulva, 164–165, 165f
Active thrombosis, 1191–1193 380f–381f Adhesions
Acute atherosis, 1154–1155 stratified type of, 388 fallopian tubes and, 731, 734f
Acute catastrophic demise, 1183–1189 subtle variants of, 388 of ovary, 762–763, 763f
amniotic fluid embolism and, 1188 subtypes of, 385–388 Adipose tissue, 520, 520f
placental abruption and, 1184–1185, superficial, 388 Adnexal gland
1186f at transformation zone, 386f benign tumors of, 102t, 106–111
ruptured vasa previa and, 1185–1187, tubal subtype of, 387–388 carcinomas of, 172
1187f Adenocarcinomas arising in diverticula, 177 Paget disease with, 168f

Note: Page numbers followed by “f ” refer to illustrations; page numbers followed by “t” refer to tables; page numbers followed by “b” refer to boxes.
1254